Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Biological Replicate ID | Conc Unit | GR50 | GEC50 | GRmax | GRinf | GR Hill Coefficient | GR_AOC | GR r2 | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCC1419 | HER2amp | Luminal | Cetuximab | EGFR | ErbB | 7820.042 | uM | inf | inf | 1.0221 | 1.0221 | 0.0000 | -0.0483 | -28.6122 | 0.5216 | |
HCC1419 | HER2amp | Luminal | Cetuximab | EGFR | ErbB | 10019.124 | uM | inf | inf | 0.9810 | 0.9810 | 0.0000 | -0.0457 | -3.7312 | 0.5356 | |
HCC1419 | HER2amp | Luminal | Cetuximab | EGFR | ErbB | 7821.042 | uM | inf | inf | 0.7843 | 0.7843 | 0.0000 | 0.1193 | -0.0824 | 0.5522 | |
HCC1419 | HER2amp | Luminal | Cetuximab | EGFR | ErbB | 9278.026 | uM | inf | inf | 0.8659 | 0.8659 | 0.0000 | 0.0594 | -0.0671 | 0.3395 | |
HCC1428 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 7441.102 | uM | inf | inf | 0.9761 | 0.9761 | 0.0000 | 0.0202 | 0.1949 | 0.9144 | |
HCC1569 | HER2amp | Basal A | Cetuximab | EGFR | ErbB | 7824.018 | uM | inf | inf | 1.0500 | 1.0500 | 0.0000 | -0.0500 | -inf | 1.3115 | |
HCC1569 | HER2amp | Basal A | Cetuximab | EGFR | ErbB | 9347.026 | uM | inf | inf | 1.0500 | 1.0500 | 0.0000 | -0.0441 | -22.3629 | 1.2965 | |
HCC1569 | HER2amp | Basal A | Cetuximab | EGFR | ErbB | 7447.102 | uM | inf | inf | 0.9613 | 0.9613 | 0.0000 | 0.0386 | 0.0310 | 1.6467 | |
HCC70 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 7857.042 | uM | inf | 0.00139 | 0.7456 | 0.7944 | 5.0000 | 0.1040 | 0.8457 | 1.1910 | |
HCC70 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 7856.018 | uM | inf | inf | 0.8811 | 0.8811 | 0.0000 | 0.0121 | 0.4683 | 0.9388 | |
HCC1806 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 7830.018 | uM | inf | inf | 0.8437 | 0.8437 | 0.0000 | -0.0352 | 0.4991 | 1.5320 | |
HCC1806 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 9376.026 | uM | inf | 0.00355 | 0.6382 | 0.6973 | 1.1036 | 0.0999 | 0.9151 | 1.6827 | |
AU565 | HER2amp | Luminal | Cetuximab | EGFR | ErbB | 7793.018 | uM | inf | inf | 0.9318 | 0.9318 | 0.0000 | 0.0067 | 0.3477 | 1.3186 | |
184B5 | NM | Basal | Cetuximab | EGFR | ErbB | 9095.026 | uM | 0.04089 | 0.03186 | 0.1205 | 0.1008 | 0.9024 | 0.1873 | 0.9743 | 1.0168 | |
600MPE | HR+ | Luminal | Cetuximab | EGFR | ErbB | 9118.006 | uM | inf | inf | 0.8545 | 0.8545 | 0.0000 | 0.0747 | 0.3005 | 1.1089 | |
600MPE | HR+ | Luminal | Cetuximab | EGFR | ErbB | 7791.018 | uM | inf | inf | 0.8577 | 0.8577 | 0.0000 | -0.0332 | 0.4860 | 0.8558 | |
184A1 | NM | Basal | Cetuximab | EGFR | ErbB | 7787.018 | uM | inf | inf | 0.4652 | 0.4652 | 0.0000 | 0.3838 | -0.0013 | 0.3791 | |
AU565 | HER2amp | Luminal | Cetuximab | EGFR | ErbB | 9035.018 | uM | inf | inf | 0.9083 | 0.9083 | 0.0000 | 0.0297 | 0.4162 | 2.1555 | |
HCC1187 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 7812.042 | uM | inf | inf | 0.5614 | 0.5614 | 0.0000 | 0.0267 | 0.3674 | 0.9722 | |
BT-20 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 5903.102 | uM | inf | 0.01035 | 0.7898 | 0.7837 | 0.8245 | 0.0669 | 0.9137 | 1.2557 | |
184A1 | NM | Basal | Cetuximab | EGFR | ErbB | 9047.026 | uM | 0.00360 | 0.01403 | -0.2605 | -0.4617 | 0.4805 | 0.4918 | 0.8777 | 0.5972 | |
BT-474 | HER2amp | Luminal | Cetuximab | EGFR | ErbB | 9158.123 | uM | inf | inf | 0.7610 | 0.7610 | 0.0000 | 0.0813 | 0.5069 | 0.8769 | |
BT-483 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 7801.018 | uM | inf | inf | 0.7533 | 0.7533 | 0.0000 | 0.1055 | 0.0672 | 0.5913 | |
LY2 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 10264.026 | uM | inf | inf | 0.9706 | 0.9706 | 0.0000 | -0.0006 | 0.1039 | 1.5047 | |
LY2 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 7865.018 | uM | inf | inf | -0.1870 | -0.1870 | 0.0000 | 0.5240 | -0.0010 | 1.1920 |